ChairScott M. Robertson 

Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Scott Robertson (Chair)Kaiserx
John Hatem (Scribe)Independent Consultantx
Isaac VetterEpic
Christof GessnerHL7 Germany
Shelly SpiroPharmacy HIT Collaborativex
Brad WiseHumana
Stephen ChuADHA
Danielle Bancroft

Corey SpearsMITREx
Frank McKinneyPOCPx
Dave HillMITREx
Peter SergentHL7 New Zealandx
Joe QuinnSmile CDRx
Tim McNeilSurescriptx
Reed D. GelzerTrustworthy EHR
Margaret WeikerNCPDP
Melva PetersJenaker Consultingx
Anthony DiDonato

Agenda Items and Notes

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

Discussion of MedicationKnowledge changes (Jean Duteau)

  • - no updates

Catalog Updates (John Hatem)

Workflow Update (John Hatem) 

Healthcare Product Update (John Hatem)

    • no pharmacy issues discussed. 
    • Discussed Device tracker items. 

NCPDP Updates (NCPDP Members)

    • NCPDP Task Group working on Patient Consent - for specialty prescribing
        • Meeting will resume in January, 2022
    • RealTime Pharmacy Benefit Check for Consumers
        • Meeting will resume in January, 2022
    • Consultant Pharmacist Task Force
    • Specialty Enrolment PSS (Frank/Maggie)
        • Meeting will resume in January, 2022

Meeting information can be obtained at

Global Supply Chain Project (Scott)


Medication List Guidance project (John)

  • - Provided an update of current work on Dec 6th call.  Minor updates to the work completed this week.  


Pharmacy Templates

  • - items below are carried over from last week 
    • waiting for requirements from Christof and then will decide on next steps for new version
    • Still waiting for approval of change request in Europe
      • additional elements to be added - part relationship

PDex Formulary (Corey)

  • - items below are carried over from last week
    • Bulk Data change - not included in the next ballot
    • Updates to PSS reviewed in today's meeting by Corey
      • included non-patient specific data updates
      • minor change to reflect bulk data as an example method
    • PDEx formulary is in ballot

Medication List Project from EHR 

    • John H met with Reed last week and discussed our Med List work
    • Scott also met with Reed last week and discussed (add in here for context)
    • No new action items other than Reed's suggestion to follow the NCPDP work  
      • Will attend NCPDP meeting after the first of the year that are related to Med Rec process


International Patient Access

  • - no updates

FHIR (Group)

BR&R managed resources review

  • no recent meetings

New Resource - FormularyItem

  • January 21 - new resource proposal deadline for May 2022 ballot

Preparation for Normative

  • Melva to work with John about QA needed

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

Any Other Business

Next meeting